Clinical Trials Browser

Phase 1/2 × Has results × Arsenic Trioxide × Clear all

NCT00469209 2020-09-24

Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients

Phase 1/2 Completed

60 enrolled 7 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01791894 2018-06-08

ATO

Phase 1/2 Completed

5 enrolled 9 charts

Carcinoma, Basal Cell, Skin Neoplasms

NCT00661544 2013-03-04

Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients

Phase 1/2 Completed

48 enrolled 3 charts

Multiple Myeloma